{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:20:00Z","timestamp":1775064000688,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Council, R.O.C","award":["MOST 105-3011-F-010-005"],"award-info":[{"award-number":["MOST 105-3011-F-010-005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>The use of atropine is currently one of the most effective methods used to prevent myopia progression. The purpose of this study was to investigate atropine adherence in preschool children with myopia, to explain the context of treatment through caregivers, and to identify barriers and facilitators of using atropine. We conducted in-depth interviews with 60 caregivers of children (parents, kindergarten teachers and nurses) in four different areas ranging from large cities to rural areas in Taiwan. Based on the social ecological theory model, the recorded text was systematically analyzed, extracted, edited and indexed by NVivo 12 Plus. After interviewing caregivers, we determined the barriers and facilitators at the four levels of influence (children, parents, school, and hospital and society). Barriers included the side effects, parental neglect, lack of understanding of long-term drug use, lack of conducive environment, and lack of friendly medical services. Facilitators included overcoming side effects, parental responsibility, myopia progression on treatment adherence, teacher support, management by nurses, navigation by ophthalmologists, and model learning. Hence, establishing a social support network, discussing the experience of individualized drug use in preschool children, and establishing a friendly medical intervention strategy can raise awareness among parents regarding myopia, and improve atropine adherence in preschool children.<\/jats:p>","DOI":"10.3390\/children11091087","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:30:02Z","timestamp":1725514202000},"page":"1087","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Context of Atropine Adherence in Preschool Children with Early-Onset Myopia: A Qualitative Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-7406","authenticated-orcid":false,"given":"Ciao-Lin","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Child Care and Education, Hungkuang University, No. 1018, Sec. 6, Taiwan Boulevard, Shalu District, Taichung City 433304, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Grzybowski, A., Kanclerz, P., Tsubota, K., Lanca, C., and Saw, S.M. (2020). A review on the epidemiology of myopia in school children worldwide. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-019-1220-0"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.47102\/https:\/\/doi.org\/10.47102\/annals-acadmedsg.V33N1p27","article-title":"Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000","volume":"33","author":"Lin","year":"2004","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: A review and meta-analysis","volume":"61","author":"Haarman","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2013.256","article-title":"Myopia, an underrated global challenge to vision: Where the current data takes us on myopia control","volume":"28","author":"Holden","year":"2014","journal-title":"Eye"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.ophtha.2021.04.032","article-title":"The risks and benefits of myopia control","volume":"128","author":"Bullimore","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1167\/iovs.13-11861","article-title":"Compliance with occlusion therapy for childhood amblyopia","volume":"54","author":"Wallace","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/ijo.IJO_1457_18","article-title":"Consensus statement and guidelines for use of dilute atropine sulphate in myopia control","volume":"67","author":"Kesarwani","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: A report by the American academy of ophthalmology","volume":"124","author":"Pineles","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","article-title":"A pilot study on the efficacy and safety of 0.01% atropine in German schoolchildren with progressive myopia","volume":"8","author":"Joachimsen","year":"2019","journal-title":"Ophthalmol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","article-title":"Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: First year results","volume":"62","author":"Kinoshita","year":"2023","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1111\/aos.14166","article-title":"Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients","volume":"97","author":"Sacchi","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","article-title":"Atropine slows myopia progression more in Asian than white children by meta-analysis","volume":"91","author":"Li","year":"2014","journal-title":"Optom. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/eye.2012.279","article-title":"Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007: A nationwide study","volume":"27","author":"Fang","year":"2013","journal-title":"Eye"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0161-6420(97)30048-7","article-title":"Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia","volume":"104","author":"Simons","year":"1997","journal-title":"Ophthalmology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_16","first-page":"CD004916","article-title":"Interventions to slow progression of myopia in children","volume":"1","author":"Walline","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2011.0017","article-title":"Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: A meta-analysis of controlled clinical trials","volume":"27","author":"Song","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_18","first-page":"5710","article-title":"Implementation of atropine treatment for progressive myopia in children","volume":"54","author":"Kok","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","article-title":"Update in myopia and treatment strategy of atropine use in myopia control","volume":"33","author":"Wu","year":"2019","journal-title":"Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/opo.12455","article-title":"Parental attitudes to myopia: A key agent of change for myopia control?","volume":"38","author":"McCrann","year":"2018","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_21","unstructured":"World Health Organization (2008). The Global Burden of Disease: 2004 Update, World Health Organization."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/09273972.2010.529983","article-title":"How Dutch orthoptists deal with noncompliance with occlusion therapy for amblyopia","volume":"18","author":"Tjiam","year":"2010","journal-title":"Strabismus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/OPX.0000000000000010","article-title":"Factors affecting eye care-seeking behavior of parents for their children","volume":"90","author":"Balasubramaniam","year":"2013","journal-title":"Optom. Vis. Sci."},{"key":"ref_24","first-page":"793","article-title":"Promoting medication adherence in children","volume":"74","author":"Gardiner","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.21101\/cejph.a4823","article-title":"Trends in perception of psychosocial school environment: HBSC study 2002\u20132014 in the Czech Republic","volume":"25","author":"Hollein","year":"2017","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_26","first-page":"55","article-title":"Using a qualitative triangulation method to explore the challenge of myopia prevention in school children for the role of school health nursing","volume":"3","author":"Chiu","year":"2016","journal-title":"Int. J. Nurs."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/tjo.tjo_24_17","article-title":"How to effectively manage myopia","volume":"7","author":"Chuang","year":"2017","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: A meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaapos.2010.09.020","article-title":"An evidence-based update on myopia and interventions to retard its progression","volume":"15","author":"Leo","year":"2011","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.86.11.1306","article-title":"Myopia: Attempts to arrest progression","volume":"86","author":"Saw","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wu, L.J., You, Q.S., Duan, J.L., Luo, Y.X., Liu, L.J., Li, X., Gao, Q., Zhu, H.P., He, Y., and Xu, L. (2015). Prevalence and associated factors of myopia in high-school students in Beijing. PLoS ONE., 10.","DOI":"10.1371\/journal.pone.0120764"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1059840519850619","article-title":"A nationwide study of myopia in Taiwanese school children: Family, activity, and school-related factors","volume":"37","author":"Holton","year":"2019","journal-title":"J. Sch. Nurs."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/9\/1087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:49:05Z","timestamp":1760111345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/9\/1087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["children11091087"],"URL":"https:\/\/doi.org\/10.3390\/children11091087","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}